CD4 and neoplasm: Obviously, sgCas9‐AdV/Gel injection elevated the levels of CD3+CD4+ (helper) and CD3+CD8+ (cytotoxic) T cells in tumor tissues (Figure 4A,B and Figure S14, Supporting Information), while reducing the infiltration of Tregs (Figure 4C and Figure S15, Supporting Information).